NEUE 📈 NeueHealth - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US10920V4041
NEUE: Healthcare, Clinics, Pharmacy, Laboratory, Radiology, Population Health
NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida. Web URL: https://www.neuehealth.com
Additional Sources for NEUE Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NEUE Stock Overview
Market Cap in USD | 44m |
Sector | Healthcare |
Industry | Healthcare Plans |
GiC Sub-Industry | Managed Health Care |
IPO / Inception | 2021-06-24 |
NEUE Stock Ratings
Growth 5y | -89.7% |
Fundamental | -9.36% |
Dividend | - |
Rel. Strength Industry | -1533 |
Analysts | 2.5/5 |
Fair Price Momentum | 3.85 USD |
Fair Price DCF | - |
NEUE Dividends
No Dividends PaidNEUE Growth Ratios
Growth Correlation 3m | -24.5% |
Growth Correlation 12m | -79.6% |
Growth Correlation 5y | -97.8% |
CAGR 5y | -77.01% |
CAGR/Mean DD 5y | -0.86 |
Sharpe Ratio 12m | 0.33 |
Alpha | -48.54 |
Beta | 1.14 |
Volatility | 500.05% |
Current Volume | 46.7k |
Average Volume 20d | 67.8k |
What is the price of NEUE stocks?
As of January 03, 2025, the stock is trading at USD 7.42 with a total of 46,700 shares traded.
Over the past week, the price has changed by +2.06%, over one month by +47.51%, over three months by +40.31% and over the past year by -10.06%.
As of January 03, 2025, the stock is trading at USD 7.42 with a total of 46,700 shares traded.
Over the past week, the price has changed by +2.06%, over one month by +47.51%, over three months by +40.31% and over the past year by -10.06%.
Is NeueHealth a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, NeueHealth is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -9.36 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NEUE as of January 2025 is 3.85. This means that NEUE is currently overvalued and has a potential downside of -48.11%.
Neither. Based on ValueRay Fundamental Analyses, NeueHealth is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -9.36 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NEUE as of January 2025 is 3.85. This means that NEUE is currently overvalued and has a potential downside of -48.11%.
Is NEUE a buy, sell or hold?
NeueHealth has received a consensus analysts rating of 2.50. Therefor, it is recommend to sell NEUE.
NeueHealth has received a consensus analysts rating of 2.50. Therefor, it is recommend to sell NEUE.
- Strong Buy: 0
- Buy: 0
- Hold: 1
- Sell: 1
- Strong Sell: 0
What are the forecast for NEUE stock price target?
According to ValueRays Forecast Model, NEUE NeueHealth will be worth about 4.2 in January 2026. The stock is currently trading at 7.42. This means that the stock has a potential downside of -43.94%.
According to ValueRays Forecast Model, NEUE NeueHealth will be worth about 4.2 in January 2026. The stock is currently trading at 7.42. This means that the stock has a potential downside of -43.94%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 7 | -5.7% |
Analysts Target Price | 24.3 | 227.9% |
ValueRay Target Price | 4.2 | -43.9% |